This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: The University of Texas System. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Chisato Tsuchikama: Innovator in Antibody Drug Conjugates
Introduction
Chisato Tsuchikama is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of biochemistry, particularly in the development of antibody drug conjugates. With a total of 2 patents to her name, her work is paving the way for advancements in targeted therapies.
Latest Patents
Tsuchikama's latest patents focus on linkers for antibody drug conjugates. These patents provide innovative compounds that enhance the efficacy of therapeutic agents. The disclosures include methods for preparing these compounds and their applications in pharmaceutical compositions. The compounds are designed to improve the delivery and effectiveness of drugs, showcasing her commitment to advancing medical science.
Career Highlights
Chisato Tsuchikama is affiliated with the University of Texas System, where she continues her research and development efforts. Her work is characterized by a strong emphasis on practical applications in medicine, particularly in the treatment of various diseases through innovative drug delivery systems.
Collaborations
Tsuchikama collaborates with esteemed colleagues such as Kyoji Tsuchikama and Yasuaki Anami. These partnerships enhance her research capabilities and contribute to the success of her projects.
Conclusion
Chisato Tsuchikama is a trailblazer in the field of antibody drug conjugates, with her innovative patents and collaborative efforts driving advancements in targeted therapies. Her contributions are vital to the future of medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
